Nasdaq
RGNX
REGENXBIO Inc.
- Health Care
- Listed 2015
- 1 day
- +7.4%
- 1 month
- −24.9%
- 1 year
- +37.1%
$11.28 · Mkt cap $583M
At the 6 Aug 2026 close
Nasdaq
REGENXBIO Inc.
$11.28 · Mkt cap $583M
At the 6 Aug 2026 close
REGENXBIO Inc. trades under the ticker RGNX on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2015. Its market capitalisation is $583M. The last closing price was $11.28, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +37.1%, and −24.9% over the past month. Returns are price returns and exclude dividends.
This page exists because RGNX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.